The metabolomics market will register a CAGR of nearly 12% by 2023

Friday, February 8, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Feb. 7, 2019 /PRNewswire/ --

About this marketHigh potential for new techniques in metabolomics

to emerge as a major trend. New techniques in metabolomics are gaining widespread popularity among scientists and researchers due to their increased potential for fast and simultaneous fingerprinting of a vast number of metabolites. Many of the above
professionals use multiple separation techniques such as high-performance liquid chromatography (HPLC), UPLC, ion chromatography-mass spectrometry (IC-MS), GC, and LC, and other detection techniques such as MS-NMR, surface-based mass analysis, and metabolite profiling for successful and comprehensive metabolite coverage. Technavio' s analysts have predicted that the metabolomics market will register a CAGR of nearly 12% by 2023.Read the full report: https://www.reportlinker.com/p05731035 Market OverviewRising demand for early and accurate diagnosisIn recent years, the field of metabolomics has shown significant potential in early disease diagnosis, therapy monitoring, and understanding the pathogenesis of different diseases. Since metabolomics methods focus on analytical techniques such as N MR spectroscopy and MS, the analyses from these high-resolution methods using advanced chemometric approaches can provide a powerful platform for translational/clinical research and diagnostic applications.Lack of skilled professionals Research analysis of samples using metabolomics tools requires the assistance of skilled professionals to design experiments, collect the samples, extract the samples, and generate metabolomic data. These professionals must have in-depth knowledge of analytical methods such as mass spectrometry and nuclear magnetic resonance, which are used in performing experiments.For the detailed list of factors that will drive and challenge the growth of the metabolomics market during the 2019-2023, view our report.Competitive LandscapeThe market appears to be fragmented and with the presence of several companies including Bruker and Human Metabolome Technologies the competitive environment is quite intense. Factors such as the rising demand for early and accurate diagnosis and the high potential for new techniques in metabolomics, will provide considerable growth opportunities to metabolomics manufactures. Agilent Technologies, Bio-Rad Laboratories, Bruker, Human Metabolome Technologies, and METABOLON are some of the major companies covered in this report.Read the full report: https://www.reportlinker.com/p05731035 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-metabolomics-market-will-register-a-cagr-of-nearly-12-by-2023-300791803.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store